Clinical Trials Logo

Clinical Trial Summary

The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.


Clinical Trial Description

Acne rosacea is a chronic inflammatory disease with different components including inflammatory lesions (papules/pustules), erythema and telangiectasia. Brimonidine 0.33% Gel primarily affects the erythematous components of rosacea. As such, combination treatment with a standard rosacea treatment, such as Finacea 15% Gel, may provide additional relief for the inflammatory component of rosacea. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02147691
Study type Interventional
Source Derm Research, PLLC
Contact
Status Completed
Phase Phase 4
Start date May 2014
Completion date February 2015

See also
  Status Clinical Trial Phase
Completed NCT03064438 - Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea Phase 2
Active, not recruiting NCT05108025 - DMT310-005 Topical in the Treatment of Acne Rosacea Phase 2
Completed NCT02270411 - Inflammatory Cells From Various Pathologies
Recruiting NCT04214483 - A Pilot Study to Explore the Role of Gut Flora in Acne
Completed NCT00041977 - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea Phase 3
Completed NCT03003104 - DMT210 Topical Gel in the Treatment of Acne Rosacea Phase 2
Completed NCT00580723 - Effects of PRK 124 Lotion in Acne Rosacea Phase 1/Phase 2
Completed NCT04555525 - A Pilot Study on the Use of Seysara for Rosacea Phase 4